[O8] Oral Session 8　Lung Cancer / Thoracic Cancer 2（Immune Checkpoint Inhibitors）
【E】

[O8-3] Pembrolizumab Plus Chemo in Asian Patients With PD-L1 Negative Advanced NSCLC: Pooled Analysis of KN021G, 189 and 407

^○Takayasu Kurata¹, James Chih-Hsin Yang², Isamu Okamoto³, Li Zhang⁴, Jie Hu⁵, Donglin Wang⁶, Chengping Hu⁷, Jianying Zhou⁸, Lin Wu⁹, Lejie Cao¹⁰, Jiwei Liu¹¹, Helong Zhang¹², Hong Sun¹³, Ziping Wang¹⁴, Hongjun Gao¹⁵, Yan Yan¹⁶, Suijun Xiao¹⁶, Jianxin Lin¹⁷, M. Catherine Pietanza¹⁷, Ying Cheng¹⁸ (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China, 3.Kyushu University Hospital, Fukuoka, Japan, 4.Respiratory Medicine Department, Peking Union Medical College Hospital, Beijing, China, 5.Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China, 6.Department of Oncology, Chongqing Cancer Hospital, Chongqing, China, 7.Department of Respirology and Critical Care Medicine, Xiangya Hospital Central South University, Changsha, China, 8.Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China, 9.Department of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China, 10.Department of Respiration, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China, 11.Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 12.Department of Oncology, Tang Du Hospital, The Fourth Military Medical University, Xi'an, China, 13.Department of Oncology, The First Affiliated Hospital of Xi’An Jiaotong University, Xi'an, China, 14.Department of Thoracic Medical Oncology, Beijing Cancer Hospital, Beijing, China, 15.Department of Pulmonary Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China, 16.MSD, Shanghai, China, 17.Merck & Co., Inc., Kenilworth, NJ, USA, 18.Department of Medical Oncology, Jilin Cancer Hospital, Chaoyang Borough, Changchun, China)